These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29893355)

  • 1. Impact of Residual SYNTAX Score and Its Derived Indexes on Clinical Outcomes after Percutaneous Coronary Intervention: Data from a Large Single Center.
    Song Y; Gao Z; Tang XF; Jiang P; Xu JJ; Yao Y; Li JX; Zhao XY; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Chin Med J (Engl); 2018 Jun; 131(12):1390-1396. PubMed ID: 29893355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index.
    Généreux P; Campos CM; Yadav M; Palmerini T; Caixeta A; Xu K; Francese DP; Dangas GD; Mehran R; Leon MB; Serruys PW; Stone GW
    EuroIntervention; 2015 Oct; 11(6):634-42. PubMed ID: 25308300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of residual coronary lesions on outcomes of myocardial infarction patients with multi-vessel disease.
    Ahmed TAN; Othman AAA; Demitry SR; Elmaghraby KM
    BMC Cardiovasc Disord; 2024 Jan; 24(1):68. PubMed ID: 38262995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objectifying the level of incomplete revascularization by the residual SYNTAX score and evaluating its impact on the one-year outcome of percutaneous coronary intervention in patients with multi-vessel disease.
    Alidoosti M; Saroukhani S; Lotfi-Tokaldany M; Jalali A; Sobh-Rakhshankhah A
    Cardiovasc Revasc Med; 2016; 17(5):308-12. PubMed ID: 27198530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.
    Capodanno D; Chisari A; Giacoppo D; Bonura S; Lavanco V; Capranzano P; Caggegi A; Ministeri M; Tamburino C
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):333-40. PubMed ID: 22936604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.
    Park KW; Kang J; Kang SH; Ahn HS; Kang HJ; Koo BK; Chae IH; Youn TJ; Oh BH; Park YB; Kandzari D; Kim HS
    Am Heart J; 2014 Mar; 167(3):384-392.e5. PubMed ID: 24576524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Incomplete Revascularization on Long-Term Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention.
    Azzalini L; Candilio L; Ojeda S; Dens J; La Manna A; Benincasa S; Bellini B; Hidalgo F; Chavarría J; Maeremans J; Gravina G; Miccichè E; D'Agosta G; Venuti G; Tamburino C; Pan M; Carlino M; Colombo A
    Am J Cardiol; 2018 May; 121(10):1138-1148. PubMed ID: 29563016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Residual Coronary Stenoses After Functionally Complete Revascularization.
    Kobayashi Y; Nam CW; Tonino PA; Kimura T; De Bruyne B; Pijls NH; Fearon WF;
    J Am Coll Cardiol; 2016 Apr; 67(14):1701-11. PubMed ID: 27056776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal left anterior descending coronary artery stenosis should be considered when using the prognostic value of the residual SYNTAX score: Data from 10343 consecutive patients with long-term follow up in the real world.
    Gao G; Feng L; Zhang D; Song C; Zhu C; Song W; Zhao Y; Xu B; Yin D; Dou K
    Catheter Cardiovasc Interv; 2018 Feb; 91(S1):639-645. PubMed ID: 29542281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of multiple risk scores in assessing medium-to long-term clinical outcomes in unstable angina / non-ST-elevation myocardial infarction patients undergoing multi vessel percutaneous coronary intervention: An observational, registry-based study in India.
    Sebastian G; Pillai V; Manzil A; Damodara R; Kalra I; Abdul Z; Mathew O
    Indian Heart J; 2021; 73(5):555-560. PubMed ID: 34627568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Yan L; Li P; Wang Y; Han D; Li S; Zhang J; Jiang M; Fan L; Han Y; Cao F
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1(Suppl 1):606-615. PubMed ID: 31868307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.
    Witberg G; Lavi I; Assali A; Vaknin-Assa H; Lev E; Kornowski R
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):3-10. PubMed ID: 25413668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of residual SYNTAX score and SYNTAX revascularization index for contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction.
    Çamci S; Yilmaz E
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5793-5801. PubMed ID: 36066154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of SYNTAX-Ⅱ score on prognosis of patients with chronic total occlusion undergoing percutaneous coronary intervention].
    Wang J; Xu HB; Qiao SB; Guan FH; Hu WX; Yang JS; Yuan JG; Cui L; Song M; Zhang P; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Dec; 50(12):1186-1192. PubMed ID: 36517439
    [No Abstract]   [Full Text] [Related]  

  • 16. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between thrombolysis in myocardial infarction risk index and the severity of coronary artery lesions and long-term outcome in acute myocardial infarction patients undergoing percutaneous coronary intervention].
    Chen Y; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Jiang L; Liu R; Zhao XY; Gao LJ; Song L; Zhang Y; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):874-881. PubMed ID: 30462976
    [No Abstract]   [Full Text] [Related]  

  • 18. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of residual SYNTAX score in patients with ST-elevation myocardial infarction and multivessel disease: Analysis of an 8-year all-comers registry.
    Braga CG; Cid-Alvarez AB; Diéguez AR; Alvarez BA; Otero DL; Sánchez RO; Pena XS; Salvado VG; Trillo-Nouche R; González-Juanatey JR
    Int J Cardiol; 2017 Sep; 243():21-26. PubMed ID: 28532984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.